ST. JOHN’s, CANADA (August, 2011) – UPTT Inc., a developer and marketer of innovative new products, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(K) clearance as a Class I medical device to market the One Pass Ostomy Draining Device (OPODD™), an exceptionally innovative device that truly supports ostomates in their daily lives.
The OPODD™ is a hand-held device that supports daily care of pouch draining for ostomates. People who have had colostomy or ileostomy surgeries that utilize a pouch would benefit from using the OPODD™ Device to more effectively and efficiently drain the pouch. The combination of significant time reduction (performed in seconds), hygienic improvements, and odour reduction implies that ostomates can have more flexibility as to “where” this procedure can be performed. With the aid of the OPODD™ Device, the pouch can be comfortably drained in a public washroom or workplace with comfort and ease, and provide a sense of cleanliness to the patient.
The OPODD™ was first introduced to global healthcare professionals at the WOCN/WCET Joint Meeting in New Orleans, LA in June, 2011. “The response was overwhelming”, says Anthony Janes, COO of UPTT Inc, “and front-line healthcare professionals immediately saw the uniqueness and important value of the innovation that would bring benefit to them in their duties, and more important to their patients.”
“This is a real innovation which will improve the quality of life of ostomates, and we feel from speaking to ostomates around the world, the OPODD™ innovation is the best to come to the industry in years,” says Janes. “The key hallmark of the innovation came from our CEO, Phil Rondeau, who battled Crohn’s, and had an ileostomy, but needed to work on an assembly line. Phil developed the prototype which he used over four years and enabled him to seamlessly work, and enjoy his personal and social life fully.”
“Convenience you can depend on”, is our key phrase says Rondeau, “since it tells ostomates that we know from experience what is important to them; and the OPODD™ gave me the confidence to really live my life rather than have the surgery determine my life.”
The OPODD™ is now available in Canada, the United States, and within weeks will be available in the Euopean Union.
About UPTT Inc.
UPTT Inc., a developer and marketer of innovative new products by ostomates for ostomates. The goal of the company is to bring the OPODD™ around the world to benefit patients, and community and hospital care. The company is based in St. John’s, Canada.